IM Cannabis Corp. announced its financial results for the second quarter ended June 30, 2025, reporting a revenue of $12.696 million. This represents a 14% decline compared to $14.750 million in Q2 2024, primarily attributed to the ongoing conflict in Israel and supply chain delays, which impacted revenue by approximately $5 million.
Despite the revenue challenges, the company achieved a 306% increase in gross profit, reaching $3.4 million in Q2 2025 compared to $0.8 million in Q2 2024. Non-IFRS Adjusted EBITDA improved by 105%, turning into a profit of $0.1 million from a $2.3 million loss in the prior year period.
The net loss for the quarter was $0.194 million, a significant improvement from a $3.456 million net loss in Q2 2024. These results reflect the company's disciplined cost management and operational efficiency, positioning it for sustainable growth as market conditions normalize.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.